IL206641B
A recombinant or isolated humanized or chimeric antibody, or antigen binding fragment thereof, that specifically binds to a neoepitope of human amyloid a peptide, a pharmaceutical composition comprising the antibody and its use in the preparation of a medicament for the treatment of amyloidosis
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
70 members in 22 offices
Priority claims12
| Document | Office | Kind | Date |
|---|---|---|---|
| 754407 | United States of America | P | |
| 754407 | United States of America | P | |
| 9593208 | United States of America | P | |
| 9593208 | United States of America | P | |
| 2008088493 | United States of America | W | |
| 2008088493 | United States of America | W | |
| 61007544 | – | – | – |
| 61095932 | – | – | – |
| PCTUS2008088493 | – | – | – |
| US20070007544P | – | – | – |
| US20080095932P | – | – | – |
| WO2008US88493 | – | – | – |
Members70
| Document | Office | Kind | |
|---|---|---|---|
| AU2008345022A1 | Australia | A1 | |
| CA2710984A1 | Canada | A1 | |
| WO2009086539A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2009202432A1 | United States of America | A1 | |
| WO2009086539A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2009086539A4 | World Intellectual Property Organization (WIPO) | A4 | |
| NO20101036L | Norway | L | |
| EP2237803A2 | European Patent Office (EPO) | A2 | |
| IL206641D0 | Israel | D0 | |
| KR20110011596A | Republic of Korea | A | |
| US2011038790A1 | United States of America | A1 | |
| EP2237803A4 | European Patent Office (EPO) | A4 | |
| JP2011510913A | Japan | A | |
| CN102016059A | China | A | |
| US7928203B2 | United States of America | B2 | |
| US2011218328A1 | United States of America | A1 | |
| US2011224408A1 | United States of America | A1 | |
| CO6341486A2 | Colombia | A2 | |
| US2012039878A1 | United States of America | A1 | |
| HK1156365A1 | Hong Kong, China | A1 | |
| US2012189624A1 | United States of America | A1 | |
| US8268973B2 | United States of America | B2 | |
| NZ586875A | New Zealand | A | |
| US2012321555A1 | United States of America | A1 | |
| SG186689A1 | Singapore | A1 | |
| SG187504A1 | Singapore | A1 | |
| US8404815B2 | United States of America | B2 | |
| AU2013205096A1 | Australia | A1 | |
| US8636981B2 | United States of America | B2 | |
| JP2014080434A | Japan | A | |
| EP2730659A2 | European Patent Office (EPO) | A2 | |
| US2014134103A1 | United States of America | A1 | |
| US8791243B2 | United States of America | B2 | |
| IL232956D0 | Israel | D0 | |
| CN102016059B | China | B | |
| AU2008345022B2 | Australia | B2 | |
| JP5730020B2 | Japan | B2 | |
| US2015158937A1 | United States of America | A1 | |
| EP2237803B1 | European Patent Office (EPO) | B1 | |
| ES2544679T3 | Spain | T3 | |
| DK2237803T3 | Denmark | T3 | |
| PT2237803E | Portugal | E | |
| AU2015249034A1 | Australia | A1 | |
| AU2013205096B2 | Australia | B2 | |
| PL2237803T3 | Poland | T3 | |
| JP2016003233A | Japan | A | |
| EP2730659A3 | European Patent Office (EPO) | A3 | |
| KR101603076B1 | Republic of Korea | B1 | |
| HUE025560T2 | Hungary | T2 | |
| EA201070812A1 | Eurasian Patent Organization (EAPO) | A1 | |
| US2017081396A1 | United States of America | A1 | |
| AU2015249034B2 | Australia | B2 | |
| EA201790858A2 | Eurasian Patent Organization (EAPO) | A2 | |
| AU2017248481A1 | Australia | A1 | |
| EA028356B1 | Eurasian Patent Organization (EAPO) | B1 | |
| EA201790858A3 | Eurasian Patent Organization (EAPO) | A3 | |
| CA2710984C | Canada | C | |
| US2018360934A1 | United States of America | A1 | |
| IL206641A | Israel | A | |
| IL206641BThis record | Israel | B | |
| IL232956A | Israel | A | |
| IL232956B | Israel | B | |
| AU2017248481B2 | Australia | B2 | |
| EP3693470A1 | European Patent Office (EPO) | A1 | |
| EA036059B1 | Eurasian Patent Organization (EAPO) | B1 | |
| BRPI0821949A2 | Brazil | A2 | |
| US2021008185A1 | United States of America | A1 | |
| BRPI0821949B1 | Brazil | B1 | |
| MX384227B | Mexico | B | |
| US2025268999A1 | United States of America | A1 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent grantedGrantedFF | FF | |
| Patent renewedKB | KB |
Numbers
- Publication
- 206641
- Publication, DOCDB
- 206641
- Publication, EPODOC
- IL206641
- Application
- 206641
- Application, DOCDB
- 20664110
- Application, EPODOC
- IL20100206641
Titles2
- English
- A recombinant or isolated humanized or chimeric antibody, or antigen binding fragment thereof, that specifically binds to a neoepitope of human amyloid a peptide, a pharmaceutical composition comprising the antibody and its use in the preparation of a medicament for the treatment of amyloidosis
- Hebrew
- נוגדן רקומביננטי או מאונש או מבודד או נוגדן כימרי, או מקטע קושר אנגד שלו הנקשר באופן בררני לאפיטופ חדש של פפטיד אמילואיד a מאונש, תכשיר רוקחות המכיל את הנוגדן ושימוש בו להכנת תרכובת רוקחית לטיפול באמילאוידוסיס
Classification
- CPC, 37
- C07K16/18
- A61K51/1018
- A61K39/0008
- A61K39/395
- A61P25/28
- A61K2039/505
- C07K2317/24
- C07K2317/32
- Y10S530/809
- C07K2317/34
- A61P1/04
- A61P11/00
- A61P13/12
- A61P17/00
- A61P17/02
- A61P17/06
- A61P19/00
- A61P19/02
- A61P19/04
- A61P25/00
- A61P25/02
- A61P29/00
- A61P31/04
- A61P31/06
- A61P31/08
- A61P35/00
- A61P35/02
- A61P43/00
- A61P7/00
- A61P9/00
- A61K49/00
- A61K49/16
- C07K2317/52
- C07K2317/56
- C07K2317/565
- C07K2317/567
- C07K2317/92